Do Kidney Stones Cause Leukocytes in Urine?

Kidney stones frequently cause leukocytes (white blood cells) to appear in urine, and the finding shows up in a substantial share of stone patients. In one study of 339 people with acute renal colic, about 14% had pyuria, the clinical term for elevated urinary white blood cells. But the presence of leukocytes does not automatically mean an infection is brewing. Stones provoke a local inflammatory response all on their own, and separating that sterile irritation from a genuine urinary tract infection is one of the trickier judgment calls in emergency and urological medicine.

How Stones Trigger White Blood Cells Without Infection

When a calcium oxalate crystal sits against the lining of the kidney or ureter, the body treats it much like it would treat a splinter. Cells in the kidney recognize the crystal as a foreign irritant, and the immune system mounts an inflammatory response. Research has shown that this cell-crystal reaction activates a specific molecular alarm system called the NLRP3 inflammasome, which triggers a cascade of inflammatory signals and draws white blood cells to the site of irritation.¹ Those immune cells then shed into the urine, showing up as leukocytes on a dipstick or under a microscope.

This means a person can have a completely sterile urinary tract and still test positive for leukocytes simply because a stone is sitting there provoking tissue. The inflammatory relationship also appears to be bidirectional: stones cause inflammation, and that inflammation may feed back into the stone-growing process by promoting crystal aggregation and growth.² The immune cells recruited to deal with the crystal damage can release pro-inflammatory molecules like interleukin-1β and interleukin-18, which sustain tissue injury and potentially create conditions for more crystals to form. It is less a one-time alarm and more a self-reinforcing loop.

Not All Stone Types Produce the Same Inflammatory Signal

Stone composition matters. A study comparing patients who formed brushite stones (a type of calcium phosphate) with those who formed calcium oxalate stones found that brushite stone formers had significantly higher levels of urinary leukocyte esterase, a chemical marker of white blood cell activity. The researchers checked for signs of bacterial infection, including nitrite and ammonium levels, and found no difference between the two groups. Even after adjusting for indicators of infection and the number of prior stone-removal procedures, the brushite group still had more leukocyte activity.³

This suggests that certain stone chemistries are more irritating to kidney tissue than others, producing a stronger sterile inflammatory response. For a clinician reading a urinalysis, it means that the degree of leukocyte elevation may partly reflect stone type, not just infection risk. It also complicates the picture for patients who are chronic stone formers: persistently elevated leukocytes on dipstick testing might lead to repeated courses of antibiotics that are never going to help, because the white blood cells are there because of the stone itself.

When Leukocytes Actually Do Signal Infection

Of course, leukocytes in urine can also mean a genuine urinary tract infection, and kidney stone patients are more vulnerable to that possibility than the general population. The question is how to tell the difference. In the study of 339 patients with acute renal colic, those who had pyuria were far more likely to have a positive urine culture: about 36% of the pyuria group grew bacteria on culture, compared with just 3% of those without pyuria.⁴ So while pyuria does raise the odds of true infection, the majority of pyuria cases in that study were still culture-negative. Leukocytes alone are not proof of infection.

In practice, clinicians look at the full picture. Nitrites on the dipstick suggest gram-negative bacteria are present. Fever and flank pain together raise suspicion. A urine culture remains the gold standard for confirming infection, but results take one to two days. In the meantime, the challenge is deciding whether to start antibiotics immediately or wait, a decision that has real consequences on both sides.

How Obstruction Sets the Stage for Genuine Infection

One of the main reasons kidney stones and urinary infections so often travel together is obstruction. When a stone blocks the ureter, urine backs up behind it. That stagnant urine becomes a warm, still pool where bacteria can latch onto the urinary tract lining, multiply, and establish an infection.⁵ The stone itself can also scrape and inflame the ureteral wall as it moves, creating tiny injuries that bacteria exploit.

This is why an obstructing stone with signs of infection is treated as an emergency. The combination of a blocked ureter and bacteria trapped upstream can escalate to a kidney infection (pyelonephritis) or worse. A multi-center study found that stone-associated obstructive pyelonephritis can lead to fatal septic shock, with particular risk in patients who also have diabetes or high levels of C-reactive protein, a blood marker of systemic inflammation.⁶

Speed matters in these cases. Research looking at outcomes for patients with obstructing stones and confirmed UTI found that delaying decompression, the procedure to drain the backed-up urine, increased the odds of death by about 29%.⁷ Decompression typically involves placing a ureteral stent or a nephrostomy tube to let urine drain, relieving pressure and allowing antibiotics to reach infected tissue more effectively.

The Chicken-and-Egg Problem With Infection Stones

The relationship between stones and infection runs in both directions. Some stones are actually caused by bacteria. Certain organisms, particularly those that produce an enzyme called urease, split urea in the urine into ammonia and carbon dioxide. The ammonia raises urine pH, creating an alkaline environment where magnesium, ammonium, and phosphate combine to form struvite stones, sometimes called infection stones.⁸ These stones can grow rapidly and fill the entire collecting system of the kidney (a “staghorn” configuration), harboring bacteria within their structure and making the infection nearly impossible to clear with antibiotics alone.

For a patient with a struvite stone, leukocytes in the urine are almost a given, because the stone is essentially a bacterial colony wrapped in mineral. Removing the stone is the only way to break the cycle. But even stones that are not classified as infection stones may not be as sterile as assumed.

Bacteria Hiding Inside “Non-Infectious” Stones

A striking finding from recent research upends the conventional division between “infection stones” and “metabolic stones.” Using electron microscopy and fluorescence imaging, researchers discovered that bacterial biofilms are layered between the mineral crystals inside calcium-based kidney stones, even in stones from patients who had no diagnosed urinary tract infection and whose stones were clinically classified as non-infectious.⁹ Similar bacterial structures were found on fragments from stones broken apart by lithotripsy, suggesting that bacteria may be woven into the stone-building process from the start.

If bacteria are an intrinsic part of many kidney stones, the clinical picture gets more complicated. It means that breaking a stone apart during treatment could release bacteria into the urinary tract, potentially triggering a new infection or a spike in white blood cells even in someone who appeared infection-free before the procedure. It also raises questions about whether the neat separation between “metabolic” and “infection” stones is too simplistic, and whether low-grade bacterial involvement in stone formation is far more common than traditionally thought.

Leukocytes After Stone Procedures

Anyone who has had a stone removed or broken up surgically should expect to see leukocytes in their urine for some time afterward. The procedure itself causes tissue trauma, and the body’s healing response involves sending white blood cells to the injured area. A prospective study of patients who underwent flexible ureteroscopy, a common minimally invasive stone procedure, found that about 36% had moderate leukocyte esterase levels in their postoperative urine, and nearly half had significant blood in their urine as well.¹⁰

The concern in the post-procedural period is sorting out expected healing from developing infection. Fever, worsening pain, and cloudy or foul-smelling urine are red flags that suggest something beyond normal recovery. Urine leukocytes measured during the first day or two after a procedure are virtually universal and not especially useful on their own for diagnosing a new infection. The trend matters more than any single snapshot.

This is also where stents create their own issues. Ureteral stents, commonly placed after stone surgery to keep the ureter open, are a known source of irritation and can themselves drive white blood cells into the urine. Diagnostic criteria for stent-associated urinary tract infection include white blood cells above a certain threshold in urine along with fever and bacterial growth on culture.¹¹ The longer a stent stays in, the greater the risk that bacteria colonize its surface and establish a genuine infection.

Why Preoperative Leukocyte Levels Matter

For people scheduled for surgical stone removal, the level of urinary leukocytes before the procedure turns out to be an important safety indicator. In a study of patients undergoing a type of percutaneous stone removal for large kidney stones, researchers found that preoperative urine leukocytes at or above 450 per microliter were the only independent risk factor for developing urosepsis, a life-threatening bloodstream infection, after the surgery. Other factors like stone size and the degree of hydronephrosis mattered in initial analysis, but leukocyte count was the one that held up as a standalone predictor.¹²

This has practical implications. Surgeons checking preoperative labs are not just looking at leukocytes to decide whether a UTI exists; they are gauging how safe it is to proceed. A high leukocyte count may prompt a delay in surgery, a course of antibiotics to bring inflammation and possible subclinical infection under control, or a staged approach where the kidney is drained first and the stone is removed later. These decisions can meaningfully reduce the risk of a dangerous postoperative complication.

The Antibiotic Overtreatment Problem

Because leukocytes in urine are so commonly associated with kidney stones, and because the consequences of a missed infection can be severe, there is a well-documented tendency to over-prescribe antibiotics to stone patients. An analysis of nearly 10 million kidney stone visits to U.S. emergency departments found that 17% of patients discharged the same day received an antibiotic prescription. Among those with no diagnosis code for concurrent infection, 18% still got antibiotics.¹³

That roughly one in five non-infected stone patients is walking out of the ER with unnecessary antibiotics. The logic is understandable: the urinalysis shows leukocytes, the patient is in pain, and the safe-seeming choice is to cover for a possible infection. But antibiotics carry their own risks, from allergic reactions to disruption of gut bacteria to the broader public-health concern of antimicrobial resistance. And for the patient whose white blood cells are there because of sterile crystal-driven inflammation, the antibiotics do nothing for the actual problem.

Better diagnostic tools could help. Some researchers have pointed out that combining dipstick findings with clinical context, such as whether the patient has fever, whether nitrites are present, and what the stone’s location and degree of obstruction look like on imaging, leads to better decisions than treating leukocytes as a standalone trigger for prescribing. Urine culture, though slower, remains the most reliable way to confirm whether bacteria are actually involved. For patients who are clinically stable and whose urine shows leukocytes but no nitrites and no fever, watchful waiting with close follow-up may be more appropriate than reflexive antibiotic use.

What Your Urinalysis Results Actually Tell You

If you have a kidney stone and your urinalysis comes back with elevated white blood cells, the finding is common and expected. It does not by itself mean you have a urinary tract infection. The stone is irritating tissue, your immune system is responding, and those immune cells are washing into your urine. That said, the finding does deserve attention, because the same test result can also mean a real infection is developing, and an infected obstructing stone is a genuine emergency.

A few practical anchors for interpreting the result: leukocyte esterase on a dipstick is a screening test, not a diagnosis. Nitrites, if present, are a stronger indicator of bacterial involvement because they are produced by gram-negative bacteria metabolizing nitrate in the urine. Fever, especially combined with flank pain and an obstructing stone, changes the clinical picture dramatically and warrants urgent evaluation. If you are a recurrent stone former and your dipstick routinely shows trace leukocytes, that pattern may reflect chronic low-grade inflammation from crystals rather than repeated infections, particularly if cultures come back negative.

For people managing stones at home while waiting for a stone to pass, the key symptoms to watch for are a temperature above 38°C (about 100.4°F), shaking chills, worsening or unrelenting pain despite medication, nausea and vomiting that prevent keeping fluids down, or urine that becomes frankly cloudy or foul-smelling. Any of those warrants a trip to the emergency department, regardless of what the last dipstick showed. Leukocytes on a test strip are a piece of the puzzle, but your body’s broader signals carry more weight in deciding when the situation has shifted from uncomfortable to dangerous.